Start Free Trial
Pricing
Log In
Log In
Upgrade browser for full Crunchbase experience. You're accessing Crunchbase in a browser that is no longer supported.
Learn More
Mytos Logo
Mytos Growth Score
67
CB Rank
29593
Heat Score
57
Mytos is building a fully-automated cell manufacture platform for Pharma
Founded
obfuscation
PrivateSeries A London, England, United Kingdom11-50 www.mytos.bio/
Biotechnology
Hardware
Manufacturing
Overview

Mytos
Total Funding
obfuscation
Growth Score
67
Heat Score
57

Total Funding
obfuscation
obfuscation
Series A raised
obfuscation
Growth Score67
-10 pts
in past quarter
Heat Score 57
-7 pts
in past quarter

Company Performance Metrics

Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Learn More >
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience

About Mytos

CB Rank
29593
Mytos is building a fully-automated cell manufacture platform for Pharma
Founded
obfuscation
PrivateSeries A London, England, United Kingdom11-50 www.mytos.bio/
Biotechnology
Hardware
Manufacturing

Funding Rounds

Series A
OBF
in
obfuscation
Venture - Series Unknown
OBF
in
obfuscation
Seed
OBF
in
obfuscation

Key People

Details

Legal Name Mytos Bio Limited
Operating Status Active
Company Type For Profit
Founders  Ali Afshar, Ignacio Willats
About the Company
Mytos is building a fully-automated cell manufacturing platform for biotech, starting with the drug development industry
Predictions & Insights

Growth Insight

See this Growth Insight
Mytos is
Lorem
 to be growing
Top Contributing Factors
Market Share Expansion

Growth Prediction

See this Growth Prediction
Top Contributing Factors
Key Employee Changes

Products & Services

iDEM Platform
An automated cell culture platform that performs all unit operations in cell manufacturing for regenerative medicine.
PSC Expansion (Cell Banking)
Automated expansion of pluripotent stem cells from a single vial to large-scale cell banks.

Unlock More with Crunchbase Pro
  • Full access to financial & funding data on unlimited profiles
  • Export up to 2k results/month for analysis
  • Track market signals on competitors, products, and R&D
  • Preview private company insights and predictions
Financials

Company Funding

Total Funding Amount 
obfuscation
Number of Funding Rounds 3
Unlock company funding data, including rounds, dates, amounts, and investors.
Announced Date  
Transaction Name  
Number of Investors  
Money Raised  
Lead Investors  
Funding Type  
obfuscation
Series A - Mytos Logo
Series A - Mytos
5
obfuscation
Buckley VenturesSeries A
obfuscation
Series A - Mytos Logo
Series A - Mytos
5
obfuscation
Buckley VenturesSeries A
obfuscation
Series A - Mytos Logo
Series A - Mytos
5
obfuscation
Buckley VenturesSeries A
obfuscation
Series A - Mytos Logo
Series A - Mytos
5
obfuscation
Buckley VenturesSeries A
obfuscation
Series A - Mytos Logo
Series A - Mytos
5
obfuscation
Buckley VenturesSeries A

Funding Rounds

Total Funding Amount 
obfuscation
Number of Funding Rounds 3
Unlock company funding data, including rounds, dates, amounts, and investors.
Announced Date  
Transaction Name  
Number of Investors  
Money Raised  
Lead Investors  
Funding Type  
obfuscation
Series A - Mytos Logo
Series A - Mytos
5
obfuscation
Buckley VenturesSeries A
obfuscation
Series A - Mytos Logo
Series A - Mytos
5
obfuscation
Buckley VenturesSeries A
obfuscation
Series A - Mytos Logo
Series A - Mytos
5
obfuscation
Buckley VenturesSeries A
obfuscation
Series A - Mytos Logo
Series A - Mytos
5
obfuscation
Buckley VenturesSeries A
obfuscation
Series A - Mytos Logo
Series A - Mytos
5
obfuscation
Buckley VenturesSeries A

Investors

Unlock company funding data, including rounds, dates, amounts, and investors.
Investor Name  
Lead Investor  
Funding Round  
Partners  
Cur8 Capital Logo
Cur8 Capital
—
Series A - Mytos Logo
Series A - Mytos
—
Cur8 Capital Logo
Cur8 Capital
—
Series A - Mytos Logo
Series A - Mytos
—
Cur8 Capital Logo
Cur8 Capital
—
Series A - Mytos Logo
Series A - Mytos
—
Cur8 Capital Logo
Cur8 Capital
—
Series A - Mytos Logo
Series A - Mytos
—
Cur8 Capital Logo
Cur8 Capital
—
Series A - Mytos Logo
Series A - Mytos
—
Market Intelligence
People
View Profiles & Contacts
Headcount 11-50 Employee Profiles 3 Contacts 18

Employee Profiles

News

News and Press

News•Oct 13, 2025
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•Oct 7, 2025
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•Oct 6, 2025
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•Sep 3, 2025
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
Access a complete feed of recent news and press, from product launches to leadership changes.
Technology
View Tech Report

Monthly Web Visits

2,053
-8.47%
 in past month

IT Spend

$181KThis year, Mytos is projected to spend $181K on IT, according to Aberdeen.

Active Website Tech Count

13Mytos is actively using 13 technologies for its website, according to BuiltWith. These include HSTS, CommonCrawl Top 5m, and  Apple Mobile Web App Capable.

Total IP

2The intellectual property of Mytos includes 2 registered patents primarily in the 'Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation Or Genetic Engineering' category, according to IPqwery.
Sub-Organizations
Frequently Asked Questions

Where is Mytos's headquarters? Mytos is located in London, England, United Kingdom.Who invested in Mytos? Mytos has 16 investors including Cur8 Capital and  Buckley Ventures.When was the last funding round for Mytos? Mytos closed its last funding round on
obfuscation
from a Series A round.Who are Mytos's competitors? Alternatives and possible competitors to Mytos may include Cellares, Thermo Fisher Scientific, and  Sana Biotechnology.How much funding has Mytos raised to date? Mytos has raised
obfuscation
.
Who We Are
What We Do
Helpful Links
AI Content may contain mistakes and is not legal, financial or investment advice. Learn more.
Terms of Service | Privacy Policy | Sitemap | © 2026 Crunchbase Inc. All Rights Reserved.
(5eb04bf 1)
|